Unité des Virus Émergents (UVE: Aix-Marseille Univ - IRD 190 - Inserm 1207 - IHU Méditerranée Infection), Marseille, France.
Aix Marseille Université, CNRS, AFMB UMR 7257, Marseille, France.
Antiviral Res. 2020 Apr;176:104742. doi: 10.1016/j.antiviral.2020.104742. Epub 2020 Feb 10.
In 2019, a new coronavirus (2019-nCoV) infecting Humans has emerged in Wuhan, China. Its genome has been sequenced and the genomic information promptly released. Despite a high similarity with the genome sequence of SARS-CoV and SARS-like CoVs, we identified a peculiar furin-like cleavage site in the Spike protein of the 2019-nCoV, lacking in the other SARS-like CoVs. In this article, we discuss the possible functional consequences of this cleavage site in the viral cycle, pathogenicity and its potential implication in the development of antivirals.
2019 年,一种新型冠状病毒(2019-nCoV)在中国武汉感染人类。其基因组已被测序,并及时公布了基因组信息。尽管与 SARS-CoV 和 SARS 样冠状病毒的基因组序列高度相似,但我们在 2019-nCoV 的 Spike 蛋白中发现了一个独特的类似弗林蛋白酶的切割位点,而在其他 SARS 样冠状病毒中则没有。在本文中,我们讨论了这个病毒周期中切割位点、致病性及其在抗病毒药物开发中的潜在意义的可能功能后果。